Envista (NVST) Stock Price, News & Analysis

Company Overview

Envista Holdings Corporation (NYSE: NVST) is a global dental-products and technologies company that develops, manufactures and markets equipment, consumables and digital solutions for dental professionals, laboratories and specialists. Its offerings support diagnosis, treatment planning, restorative dentistry, orthodontics, implant dentistry and related clinical procedures.

The company’s portfolio includes dental imaging systems and software, treatment units, handpieces, infection-control products, restorative materials, endodontic products, orthodontic brackets and aligners, dental implants, prosthetic components and laboratory solutions. Its brands have included DEXIS, Kerr, Nobel Biocare, Ormco and KaVo, among others.

Envista was formed through a separation from Danaher Corporation in 2019. The company serves customers through direct sales and distributors across North America, Europe, Asia-Pacific and other international markets, with products used by general dentists, dental specialists, laboratories and dental service organizations.

Key Stats

• Today's Range: $22.61 to $22.96
• 50-Day Range: $22.71 to $28.74
• 52-Week Range: $18.77 to $30.42
• Volume: 875,540 shs
• Average Volume: 2.89 million shs
• Market Capitalization: $3.66 billion
• P/E Ratio: 39.27
• Dividend Yield: N/A
• Price Target: $29.64
• Consensus Rating: Hold

Envista Stock Analysis - MarketRank™

Envista scored higher than 77% of companies evaluated by MarketBeat, and ranked 132nd out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Hold

Consensus Rating

Envista has received a consensus rating of Hold. The company's average rating score is 2.41, and is based on no strong buy ratings, 7 buy ratings, 10 hold ratings, and no sell ratings.

Upside Potential

Envista has a consensus price target of $29.64, representing about 30.1% upside from its current price of $22.79.

Amount of Analyst Coverage

Envista has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 7.19%

Earnings Growth

Earnings for Envista are expected to grow by 7.19% in the coming year, from $1.53 to $1.64 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Envista is 39.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.97.

Price to Earnings Ratio vs. Sector

The P/E ratio of Envista is 39.29, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.64.

Price to Earnings Growth Ratio

Envista has a PEG Ratio of 1.12. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Envista has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

6.42% of the float of Envista has been sold short.

Short Interest Ratio / Days to Cover

Envista has a short interest ratio ("days to cover") of 3.97, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Envista has recently decreased by 10.29%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Envista does not currently pay a dividend.

Dividend Growth

Envista does not have a long track record of dividend growth.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -0.10

News Sentiment

Envista has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Envista this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for NVST on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Envista insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $220,000.00 in company stock.

Percentage Held by Insiders

0.99% of the stock of Envista is held by insiders.

Percentage Held by Institutions

Envista has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 10/09/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NYSE:NVST
• CIK: 1757073
• Web: www.envistaco.com
• Phone: (714) 817-5418
• Fax: 714-817-5450
• Employees: 12,000
• Year Founded: 2018

Price Target and Rating

• Average Price Target for Envista: $29.64
• High Price Target: $35.00
• Low Price Target: $23.00
• Potential Upside/Downside: +30.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.41
• Research Coverage: 17 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.58
• Trailing P/E Ratio: 39.29
• Forward P/E Ratio: 14.89
• P/E Growth: 1.12
• Net Income: $47 million
• Net Margins: 3.33%
• Pretax Margin: 8.20%
• Return on Equity: 7.88%
• Return on Assets: 4.33%

Debt

• Debt-to-Equity Ratio: 0.47
• Current Ratio: 2.43
• Quick Ratio: 2.07

Sales & Book Value

• Annual Sales: $2.86 billion
• Price / Sales: 1.28
• Cash Flow: $2.15 per share
• Price / Cash Flow: 10.61
• Book Value: $18.89 per share
• Price / Book: 1.21

Miscellaneous

• Outstanding Shares: 160,618,000
• Free Float: 159,028,000
• Market Cap: $3.66 billion
• Optionable: Optionable
• Beta: 0.89